- US12529056utility2026Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
- US12497615utility2025Nucleic Acid Compositions and Methods of Multi-exon Skipping0 cites
- US12491257utility2025Compositions and Methods of Using Prkag2-targeting Antibody-oligonucleotide Conjugates0 cites
- US12486328utility2025Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
- US12427202utility2025Compositions and Methods of Treating Muscle Dystrophy0 cites
- US12364769utility2025Nucleic Acid-polypeptide Compositions and Uses Thereof0 cites
- US12365704utility2025Nucleic Acid-polypeptide Compositions and Uses Thereof0 cites
- US12359202utility2025Anti-transferrin Receptor Antibody-pmo Conjugates for Inducing DMD Exon 44 Skipping0 cites
- US12351637utility2025Nucleic Acid-polypeptide Compositions and Uses Thereof0 cites
- US12263224utility2025Compositions and Methods of Treating Muscle Atrophy and Myotonic Dystrophy0 cites
- US12234290utility2025Nucleic Acid-polypeptide Compositions and Uses Thereof0 cites
- US12157774utility2024Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
- US12104156utility2024Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
- US12071485utility2024Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
- US12071621utility2024Anti-transferrin Receptor Antibody-pmo Conjugates for Inducing DMD Exon 44 Skipping0 cites
- US12064483utility2024Nucleic Acid-polypeptide Compositions and Methods of Inducing Exon Skipping0 cites
- US12049629utility2024Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
- US12006499utility2024Una Amidites and Uses Thereof0 cites
- US11999955utility2024Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy0 cites
Page 1 of 2Next →